Integration of proteomic and clinical data for the prediction of response to immune checkpoint inhibitor therapy in non-small cell lung cancer.

被引：0
|
作者：
Shaked, Yuval
Harel, Michal
Lahav, Coren
Jacob, Eyal
Sela, Itamar
Yahalom, Galit
Elon, Yehonatan
Sharon, Ofer
Kamer, Iris
Bar, Haim
Dicker, Adam P.
Bar, Jair
Katzenelson, Rivka
Wolf, Ido
Gottfried, Maya
Abu-Amana, Mahmud
Agbarya, Abed
Nechushtan, Hovav
Moskovitz, Mor Tal
Zer, Alona
机构：
[1] Technion, Haifa, Israel
[2] OncoHost, Binyamina, Israel
[3] OncoHost LTD, Binyamina, Israel
[4] Inst Oncol, Sheba Med Ctr, Ramat Gan, Israel
[5] Univ Connecticut, Strorrs, CT USA
[6] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Philadelphia, PA 19107 USA
[7] Kaplan Med Ctr, Dept Oncol, Rehovot, Israel
[8] Tel Aviv Med Ctr, Tel Aviv, Israel
[9] Sackler Sch Med, Tel Aviv, Israel
[10] Meir Med Ctr, Kefar Sava, Israel
[11] Haemek Med Ctr, Afula, Israel
[12] Bney Zion Med Ctr, Oncol Dept, Haifa, Israel
[13] Hadassah Med Ctr, Oncol Dept, Jerusalem, Israel
[14] Rambam Med Ctr, Haifa, ON, Israel
[15] Rabin Med Ctr, Thorac Oncol Unit, Petah Tiqwa, Israel
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e21110
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21110
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Clinical predictive markers of response to immune checkpoint inhibitor therapy in advanced non-small cell lung cancer.
    Rhone, Raena
    Dumais, Katerine
    Powery, Herman W.
    Gentile, Frank
    Raez, Luis E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [2] Robust prediction of immune checkpoint inhibition therapy for non-small cell lung cancer.
    Zhang, Yiqun
    Zhao, Guodong
    He, Ning
    Wang, Lingyu
    Wang, Jianfei
    Jin, Ge
    Lin, Rongbo
    Yang, Yadong
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [3] Tobacco Use and Response to Immune Checkpoint Inhibitor Therapy in Non-Small Cell Lung Cancer
    Corke, Lucy K.
    Li, Janice J. N.
    Leighl, Natasha B.
    Eng, Lawson
    [J]. CURRENT ONCOLOGY, 2022, 29 (09) : 6260 - 6276
  • [4] The effect and safety of an immune checkpoint inhibitor rechallenge in non-small cell lung cancer.
    Watanabe, Hiromi
    Kubo, Toshio
    Ninomiya, Kiichiro
    Kudo, Kenichiro
    Minami, Daisuke
    Murakami, Etsuko
    Ochi, Nobuaki
    Ninomiya, Takashi
    Harada, Daijiro
    Yasugi, Masayuki
    Ichihara, Eiki
    Ohashi, Kadoaki
    Fujiwara, Keiichi
    Hotta, Katsuyuki
    Tabata, Masahiro
    Maeda, Yoshinobu
    Kiura, Katsuyuki
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [5] Neoadjuvant immune checkpoint inhibitor therapy in resectable non-small cell lung cancer
    Conroy, Michael R.
    Dennehy, Colum
    Forde, Patrick M.
    [J]. LUNG CANCER, 2023, 183
  • [6] PATIENT EXPERIENCE OF IMMUNE CHECKPOINT INHIBITOR THERAPY FOR NON-SMALL CELL LUNG CANCER
    Williams, Loretta A.
    Whisenant, Meagan
    Malveaux, Donna
    Singhi, Eric K.
    Altan, Mehmet
    [J]. ONCOLOGY NURSING FORUM, 2023, 50 (02)
  • [7] Immune Checkpoint Therapy in Non-Small Cell Lung Cancer
    Marrone, Kristen A.
    Brahmer, Julie R.
    [J]. CANCER JOURNAL, 2016, 22 (02): : 81 - 91
  • [8] Robust Prediction of Immune Checkpoint Inhibition Therapy for Non-Small Cell Lung Cancer
    Jiang, Jiehan
    Jin, Zheng
    Zhang, Yiqun
    Peng, Ling
    Zhang, Yue
    Zhu, Zhiruo
    Wang, Yaohui
    Tong, De
    Yang, Yining
    Wang, Jianfei
    Yang, Yadong
    Xiao, Kui
    [J]. FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [9] Exploring histological predictive biomarkers for immune checkpoint inhibitor therapy response in non-small cell lung cancer
    Cho, Uiju
    Im, Soyoung
    Park, Hyung Soon
    [J]. JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2024, 58 (02) : 49 - 58
  • [10] Immune checkpoint blockade and biomarkers of clinical response in non-small cell lung cancer
    Hallqvist, Andreas
    Rohlin, Anna
    Raghavan, Sukanya
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2020, 92 (06)
12345